Results 191 to 200 of about 15,176 (256)

Brief communication: virological response and drug resistance patterns among men who have sex with men in Yaoundé-Cameroon. [PDF]

AIDS Res Ther
Tadenfok C, Fokam J, Semengue ENJ, Olongo AS, Fako G, Beloumou GA, Nka AD, Takou D, Yagai B, Ateba JA, Kamgain T, Ndzié B, Badona F, Emmanuel B, Elise EL, Feukeng A, Anouar D, Ambe CC, Awoh RA, Ndie J, Bissek AC, Njindam I, Ndjolo A, Ndembi N, Perno CF, Nkenfou C.   +25 more
europepmc   +1 more source

Real-world efficacy and safety of CDK4/6 inhibitors plus endocrine therapy in HR+/HER2 - metastatic breast cancer: a single-institution experience. [PDF]

J Egypt Natl Canc Inst
Hussein NE, Gad AM, AbdAllah A, El Baghdady NS.   +3 more
europepmc   +1 more source

Diagnostic challenge of occult ER-positive breast carcinoma within bone marrow indolent B-cell lymphoma and response to CDK4/6 inhibitor: a case report. [PDF]

J Med Case Rep
Drittone D, Mariniello M, Esposito L, Noccioli N, Maiorana G, La Verde G, Mazzuca F, Pisegna S.   +7 more
europepmc   +1 more source

Recent Advances in Dopamine Receptor Ligands as Chemical Biology Tools. [PDF]

ACS Omega
Dorogan M, Namballa HK, Patra S, Harding WW.   +3 more
europepmc   +1 more source

Pregnancy and Neonatal Outcomes After Prenatal Exposure to Dolutegravir: Findings from the Antiretroviral Pregnancy Registry. [PDF]

J Acquir Immune Defic Syndr
Vannappagari V, Albano JD, Mofenson L, Ragone L, Cook T, Scheuerle AE, Kisare M, Short WR, Thorne C, Beckerman KP, Carneal-Frazer N, Tilson H, de Ruiter A.   +12 more
europepmc   +1 more source

Kidney abnormalities in young people living with HIV on dolutegravir-based regimens in Kampala, Uganda. [PDF]

AIDS Res Ther
Nasuuna EM, Hoffman R, Kalyesubula R, Chikwari CD, Weiss HA.   +4 more
europepmc   +1 more source

Pharmacokinetic and bioequivalence evaluation of teneligliptin hydrobromide tablets following single-dose administration in healthy Chinese volunteers under fasting and fed conditions. [PDF]

BMC Pharmacol Toxicol
Guan Z, Chen M, Wei B, Su J, Tan D, Ke J, Huang G.   +6 more
europepmc   +1 more source

Computational Approach to Select Lead-Like Compounds From an Opioid Class of Novel Psychoactive Substances. [PDF]

Chem Biodivers
Arsić B, Micić R, Kostić E, Micić A, Lukić V.   +4 more
europepmc   +1 more source

Management of Severe Abemaciclib-induced Liver Dysfunction: Feasibility of Switching to Palbociclib. [PDF]

In Vivo
Takada S, Umehara K, Watanabe K.
europepmc   +1 more source

Combination of PARP inhibitor olaparib and a vascular disrupting agent reduces tumor growth in a preclinical model of prostate cancer. [PDF]

Cancer Chemother Pharmacol
Sereti E, Evans-Axelsson S, Törnell J, Rehnmark S, Högberg M, Bjartell A.   +5 more
europepmc   +1 more source